Arterial hypertension in the elderly - Is there still a place for diuretics?;HYPERTENSION ARTERIELLE DU SUJET AGE. QUELLE PLACE RESTE-T-IL POUR LES DIURETIQUES?

Praxis

Volumn 85, Issue 5, 1996, Pages 117-125

  Dubois, D ^a   Gauchat, M ^a   Guelpa, G ^a  

^a Hopital de la Providence   (Switzerland)

Author keywords

adverse drug reaction; antihypertensive treatment by diuretics; elderly; hypertension

Indexed keywords

AMILORIDE; ANTIHYPERTENSIVE AGENT; BENDROFLUMETHIAZIDE; BUMETANIDE; CHLORTALIDONE; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; METOLAZONE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRIAMTERENE; LIPID; POTASSIUM; SODIUM;

DRUG INFORMATION; DRUG MECHANISM; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERURICEMIA; HYPOKALEMIA; HYPONATREMIA; LIVER TOXICITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PANCREATITIS; PRESCRIPTION; REVIEW; SIDE EFFECT; AGED; BLOOD; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GLUCOSE BLOOD LEVEL; METABOLIC DISORDER;

AGED; BLOOD GLUCOSE; BLOOD PRESSURE; DIURETICS; HUMANS; HYPERTENSION; LIPIDS; POTASSIUM; SODIUM; WATER-ELECTROLYTE IMBALANCE;

EID: 0030606377     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. MacMahon S., Peto R, Cutler J.: et al.: Blood pressure, stroke and coronary heart disease. Part. 1: Prolonged differences in blood pressure. Prospective observational studies corrected for the regression dilution bias. Lancet 335, 765-774, 1990.
2. Collins R., Peto R, MacMahon S. et al.: Blood pressure, stroke and coronary heart disease. Part. 2: Short-term reductions in blood pressure. Overview of randomized drug trials in their epidemiological context. Lancet 335, 827-838, 1990.
3. Cushman W. C., Khatri I, Materson B. J. et al.: Treatment of hypertension in the elderly III. Response of isolated systolic hypertension to various doses of hydrochlorothiazide. Results of Department of Veterans Affairs Cooperative Study. Arch, intern. Med. 151, 1954-1960, 1991.
4. Mann S. J., Systolic hypertension in the elderly. Pathophysiology and management. Arch, intern. Med. 152, 1984-1992, 1992.
5. Materson B. J. et al.: Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. New Engl. J. Med. 328, 914-921, 1993.
6. Amery A., Birkenhäger W., Brixko P. et al.: Mortality and morbidity results from the European Working Party on High Blood pressure in the Elderly Trial. Lancet 1, 1349-1354, 1985.
7. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). J. Am. med. Ass. 265, 3255-3264, 1991.
8. Dahlöf B., Lindholm L. H., Hansson L., Schersten B., Ekbom T., Wester P. O.: Morbidity and mortality in the Swedish trial in old patients with hypertension. Lancet II 338, 1281-1285, 1991.
9. MRC Working Party: Medical Research Council trial of treatment of hypertension in older adults. Principal results Br med. J. 304, 405-412, 1992.
10. Applegate W. B.: Hypertension in elderly patients. Ann. intern. Med. 110, 11, 901-915, 1989.
11. Fletcher A., Amery A., Birkenhäger W. et al.: Risks and benefits in the trial of the European Working Party on High Blood Pressure in the Elderly. J. Hypertens. 9, 225-230, 1991.
12. Vokonas P. S., Kannel W. B., Cupples L A.: Epidemiology and risk of hypertension in the elderly. The Framingham Study. J. Hypertens. 6 (Suppl. 1), S3-S9, 1988.
13. Staessen J., Amery A., Fagard R.: Isolated systolic hypertension in the elderly. J. Hypertens. 8, 393-405, 1990.
14. The Fifth Report of the Joint National Comittee on Detection, Evaluation and Treatment of High Blood Plessure. Archs intern. Med. 153, 154-183, 1993.
15. Sagi A , Larson M. G., Levy D., The natural history of borderline isolated systolic hypertension. New Engl. J. Med. 329, 1912-1917, 1993.
16. World Health Organization - International Society of Hypertension - Guidelines. J. Hypertens. II, 905-918, 1993.
17. Imbs J.L.: Pharmacologie des diurétiques de l'anse. Données actuelles. Actual Nephrol. Hôp. Necker, Paris. Ed. Flammarion, 153-173, 1986.
18. Reineck H. J., Stein J. H.: Mechanisms of action and clinical use of diuretics. In: The Kidney, Brenner B. M., Rector F C. (eds.). Saunders W. B., Philadelphie, 1981.
19. Colder J. A., Schachter M., Sever P. S.: Mechanisms of the direct vasodilator action of thiazide diuretics. 14th meeting of the International Society of Hypertension. Madrid, 14-19 June 1992 (abstract book p. S51).
20. Dikshit K, Vyden J. K., Forrester J. S., Chatterjee K., Prakash R., Swan H. J. C.: Renal and extra-renal hemodynamic effects of furoscmide in congestive heart failure after acute myocardial infarction. New Engl. J. Med. 288, 1087-1090, 1988.
21. Corvol P., Ménard J.: Spironolactones. Sem. Hop. Paris. 63, 1535-1542, 1987.
22. Jeunemaûre X., Charrue A., Chatellie. G., Degoulet P., Julien J., Plouin P. F, Corvol P., Ménard J.: Long term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension. Am. J. Cardiol 62, 1072-1077, 1988.
23. Krück F., Muischler E., Knauf H. (eds.): Torasemide. - Clinical pharmacology and therapeutic applications. Gustav Fischer Verlag, Stuttgart, New York, Vol. 8. No 1, 1990.
24. Krück F., Puschett J. B., guest ed.: Symposium on torasemide - pharmacology and clinical application of loop diuretics. Drugs 41 (Suppl. 3), 1-97, 1991.
25. Abramow M., Cogan E.: Les hyponatrémies induites par les diurétiques. Rev. Prat. 36, 3244-3248, 1986.
26. Ashraf N., Locksley R., Arieff S. I.: Thiazideinduced hyponatremia associated with death of neurologic damage in outpatients. Am. J. Med. 70, 1163-1168, 1981.
27. Plante G. E., Dessuralt D. L.: Hypertension in elderly patients. A comparative study between indapamide and hydrochlorothiazide. Am. J. Med. 84 (Suppl. 1B), 98-103, 1988.
28. Sunderam S. G., Mankikar G. D.: Hyponatremia in the elderly. Age Ageing. 12, 77-80, 1983.
29. Fichman M. P., Vorherr II., Kleeman C. R., Telfer N.: Diuretic-induced hyponatremia. Ann. intern. Med. 75, 853-863, 1971.
30. Dyckner T., Wester P. O., Effects of magnesium in diuretic induced hyponatremia. Lancet I, 585-586, 1981.
31. Celentano A., Galderisi M., Murredu G. F., Garofalo M., Tammaro P., de Divitiis O.: Arrhythmias, hypertension and the elderly. Holter evaluation. J. Hypertens. 6 (Suppl. 1), S29-S32, 1988.
32. Cocco G., Iselin H. V. Strozzi C. et al.: Magnesium depletion in patients on long term chlortahdone therapy for essential hypertension. Eur. J. Clin. Pharmacol. 32, 335-338, 1987.
33. Dyckner T.: Relation of cardiovascular disease to potassium and magnesium deficiencies. Am. J Cardiol. 65, 44k-46k, 1990.
34. Freis E. D.: The cardiovascular risks of thiazide diuretics. Clin. Pharmacol. Ther. 39, 3, 239-244, 1986.
35. Hannedouche T., Delgado A.: Hypokaliémie, hypomagnésémîe et arythmies ventriculaires au cours du traitement diurétique de l'hypertension artérielle. Archs. Mal. Cœur 81, 819-824, 1988.
36. Holland O. B., Nixon J V., Kuhnert I.: Diuretic-induced ventricular ectopic activity. Am. J. Med. 70, 762-768, 1981.
37. Hollifield J. W: Thiazide treatment of hypertension. Effects of thiazide diuretics on serum potassium, magnesium and ventricular ectopy. Am. J. Med. 77 (Suppl. 5A), 28-32, 1984.
38. Kuller L. H., Hulley S. B., Cohen J. D., Neaton J.: Unexpected effects of treating hypertension in men with electrocardiographic abnormalities. A critical analysis. Circulation 73, 114-123, 1987.
39. Paillard M.: Physiologie rénale et désordres hydroélectrolytiques. Hermann, Paris, 1992.
40. Papademetriou V., Burris J. F., Notargiacomo A., Fletcher R. D., Freis E. D.: Thiazide therapy is not a cause of arrythmia in patients with systemic hypertension. Arch. intern. Med. 148, 1272-1276, 1988.
41. Storstein L.: Diuretics, arrhythmias and silent myocardial ischeamia in hypertensive patients. Eur. Heart. J. 13 (Suppl. G), 81-84, 1992.
42. Tannen R. L.: Diuretic induced hypokaliemia. Kidney intern. 28, 988-1000. 1985.
43. The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline. The Hypertension Detection and Follow-Up. Cooperative Research Group. Circulation 70, 996-1003, 1984.
44. Ventricular extrasystoles during thiazide treatment: Substudy of the MRC mild hypertension trial Br. med. J. 287, 1249-1253, 1983.
45. Whelton P K., Watson A. J.: Diuretic-induced hypokaliema and cardiac-arrhythmias. Am. J. Cardiol. 58, 5A-10A, 1986.
46. Whang R., Whang D. D., Ryan M. P.: Refractory potassium repletion. A consequence of magnesium deficiency. Archs intern. Med. 152, 40-45, 1992.
47. Homer S. M.: Efficacity of intravenous magnesium in adult myocardial infarction in reducing arrhythmias and mortality. Metaanalysis of magnesium in acute myocardial infarction. Circulation. 86, 774-779, 1992.
48. Cappucio F. P , McGregor G. A.; Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J. Hypertens. 9, 465-473, 1991.
49. Linas S. L.: The role of potassium in the pathogenesis and treatment of hypertension. Kidney intern. 39, 771-786, 1991.
50. Greenblatt D. J., Koch-Weser J.: Adverse reactions to spironolactone. A report from Boston Collaborative Surveillance Program. J. Am. med. Ass. 225, 40-43, 1973.
51. Freis E. D.: Adverse effects of diuretics. Drug Saf. 7, 364-373, 1992.
52. Langford H. G., Blaufox D., Borhani N. O. et al.: Is thiazide produced uric and elevation harmful? Arch, intern. Med. 47, 645-649, 1987.
53. Hypertension Detection and Follow-up Program Cooperative Group. The effect of treatment on mortality in «mild» hypertension. New Engl. J. Med. 307, 976-980, 1982.
54. Hulley S. B., Furberg C. D., Gurland B. et al.: Systolic hypertension in the elderly Program. Antihypertensive efficacy of chtorthalidone. Am. J. Card. 56, 913-920, 1985.
55. Carlsen J. E , Kober L., Torp-Pedersen C., Johansen P.: Relation between dose of bendrofluazide anthypertensive effect and adverse biochemical effects. Br. med. J. 300, 975-978, 1990.
56. Kochar M. S., Landry K. M., Ristow S. M.: Effects of reduction in dose and discontinuation of hydrochlorothiazide in patients with controlled essential hypertension. Arch. intern. Med. 150, 1009-1011, 1990.
57. Mackay A., Oliver M. F.: Hyperosmolar nonketotic diabetic syndrome precipited by treatment with diuretics. Br. med. J. 284, 665-666, 1982.
58. Rowe P. A., Mather H. G.: Hyperosmolar nonketotic diabetic coma induced with nietolazone. Br. med. J. 291, 25-26, 1985.
59. Medical Research Council Working Party on mild to moderate hypertension. Adverse reactions to bendrofluazide and propanolol for the treatment of mild hypertension. Lancet II, 539-543, 1981.
60. Helderman J. H , Elahi D., Andersen D. K. et al.: Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32, 106-111, 1983.
61. Moller D E., Flier D. S.: Insulin resistance mechanisms, syndromes and implications. New Engl. J. Med. 325, 938-948, 1991.
62. Dollery C. T.: Diabetogenic effect of long-term diuretic therapy. In: Modern Diuretic Therapy In The Treatment of Cardiovascular and Renal Disease, Lant A. F., Wilson G. M. (eds), Excerpta Medica, Amsterdam, 320-328, 1973.
63. Stern N., Tuck M.: Drug therapy of hypertension in diabetic patients. J. Hum. Hypertens. 5, 295-305, 1991.
64. Henry M., Wehrlen M., Pelletier B., Capron M. H.: Spironolactone versus nifedipine in essential hypertension. Am. J. Cardiol. 65, 36K-38K. 1990.
65. Grunfeld J. P., Wehrlen M, Pelletier B., Capron M. H.: Spironolactone and altizide versus converting enzyme inhibitor (enalapril). Am. J. Cardiol. 65, 28K-32K, 1990.
66. Weidmann P., de Courten M., Ferrari P.: Effects of diuretics on the plasma lipid profil. Eur. Heart J. 13 (Suppl. G), 61-67, 1992.
67. Weinberger M. H.: Antihypertensive therapy and lipids: Evidence, mechanisms and implications. Arch. int. Med. 145, 1102-1105, 1985.
68. Weidmann P., Gerber A., Mordasini R.: Effects of antihypertensive therapy on serum lipoproteins. Hypertension (Suppl. III), 120-131, 1983.
69. Grimm R. H., Leon A. S., Hunningnake D. B. et al.: Effects of thiazide diuretics on plasma lipids and lipoproteins in mildly hypertensive patients. A double-blind controlled trial. Ann. int. Med. 94, 7-11, 1981.
70. Weidmann P., Ferner C., Saxenhofer H., Uehlinger D E., Trost B. N.: Serum lipoproteins during treatment with antihypertensive drugs. Drugs 35 (Suppl. 6), 118-134, 1988.
71. Moser M.: Diuretics and cardiovascular risk factors. Eur. Heart J. 13 (Suppl. G), 72-80, 1992.
72. Davidson R. A.: Hypertension in the elderly. Med. Clin. North Am. 73, 6, 1471-1481, 1989.
73. Grimm R.: The treatment of mild hypertension study. Arch. int. Med. 151, 1413-1423, 1981.
74. Weber R., Zanchi A., Brunner HR., Wueber R.: Hypertension, le traitement de l'hypertension artérielle. La place d'une approche non pharmacologique. Méd. Hyg. 53, 87-92, 1995.
75. Wasnick R. D., Benfante R. J., Yano K., Heilbrun L., Vogel J. M.: Thiazide effect on the mineral content of bone. New Engl. J. Med. 309, 344-347, 1983.
76. Falson D. T., Sloutskis D., Anderson J. J., Anthony J. M., Kiel D. P.: Thiazide diuretics and the risk of hip fracture. Results of the Framingham Study. J. Am. med. Ass. 370-373, 1991.
77. Beard K., Bulpitt C., Mascie-Taylor H., O'Malley K., Sever P., Webb S.: Management of elderly patients with sustained hypertension. Br. med. J 304, 412-416, 1992.